EssilorLuxottica Unsponsored ADR (OTCMKTS:ESLOY) Short Interest Update

EssilorLuxottica Unsponsored ADR (OTCMKTS:ESLOY – Get Free Report) saw a significant decline in short interest during the month of May. As of May 15th, there was short interest totaling 3,624 shares, a decline of 82.0% from the April 30th total of 20,151 shares. Approximately 0.0% of the company’s shares are short sold. Based on an average trading volume of 195,258 shares, the days-to-cover ratio is currently 0.0 days.

Analyst Upgrades and Downgrades

Separately, Deutsche Bank Aktiengesellschaft began coverage on EssilorLuxottica in a report on Tuesday, May 12th. They issued a “hold” rating for the company. Two investment analysts have rated the stock with a Strong Buy rating, five have assigned a Buy rating and two have issued a Hold rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Buy”.

Get EssilorLuxottica alerts:

Get Our Latest Report on EssilorLuxottica

EssilorLuxottica Trading Up 0.1%

OTCMKTS:ESLOY traded up $0.11 on Friday, reaching $101.65. The company’s stock had a trading volume of 68,484 shares, compared to its average volume of 89,103. EssilorLuxottica has a 1-year low of $96.56 and a 1-year high of $186.81. The company has a quick ratio of 0.70, a current ratio of 0.99 and a debt-to-equity ratio of 0.17. The business’s 50-day moving average price is $109.22 and its two-hundred day moving average price is $139.83.

EssilorLuxottica Company Profile

(Get Free Report)

EssilorLuxottica SE is a global ophthalmic optics company formed through the 2018 merger of France-based Essilor and Italy-based Luxottica. Headquartered near Paris, the company combines lens manufacturing, frame design and production, brand management and retail operations to provide a vertically integrated offering across the vision care value chain. Its activities span product research and development, manufacturing, wholesale distribution and retailing of spectacles, sunglasses and ophthalmic lenses.

The company’s product portfolio includes prescription and non-prescription lenses, lens coatings and treatments, and an array of eyewear brands and frames.

Featured Stories

• Five stocks we like better than EssilorLuxottica
• Costco’s Strong Quarter Still Leaves Investors With a Valuation Problem
• These 3 Software Stocks Are Buying Back Shares Hand Over Fist
• Gap Inc. Cuts Sales Outlook After Q1 Miss, Shares Drop 17%
• MongoDB’s AI Advantage Is Starting to Show Up in Results

Receive News & Ratings for EssilorLuxottica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EssilorLuxottica and related companies with MarketBeat.com's FREE daily email newsletter.